AIMS: The aim of this paper is to examine the familial aggregation of cannabis use disorders and other psychiatric conditions among first-degree relatives and spouses of probands with a cannabis use disorder. DESIGN: Controlled family study methods. SETTING: Out-patient psychiatric clinics and the local community (same geographic area). PARTICIPANTS: Two hundred and sixty-two probands with a life-time history of cannabis use disorder, alcohol dependence, anxiety disorders or no history of any disorder, and their first-degree relatives and spouses. MEASUREMENTS: Cannabis use disorders and other DSM-III-R disorders in the relatives and spouses using the Schedule for Affective Disorders and Schizophrenia. FINDINGS: Results reveal an elevated risk of life-time history of cannabis use disorders among siblings [odds ratio (OR: 3.6), adult offspring (OR): 6.9], and spouses (OR: 4.4) of probands with cannabis use disorders. There is a latent familial factor underlying cannabis use disorders that was shared partially with alcohol abuse/dependence. Comorbid mood and anxiety disorders aggregated independently from cannabis use disorders in families. Equal elevation in the magnitude of the association among the first-degree adult relatives and spouses of probands with a cannabis use disorder suggests the probable contribution of both environmental and genetic factors. CONCLUSIONS: These findings support a family-based approach to drug abuse intervention and the importance of future research concerning environmental mediators of familial transmission of drug abuse.
AIMS: The aim of this paper is to examine the familial aggregation of cannabis use disorders and other psychiatric conditions among first-degree relatives and spouses of probands with a cannabis use disorder. DESIGN: Controlled family study methods. SETTING: Out-patientpsychiatric clinics and the local community (same geographic area). PARTICIPANTS: Two hundred and sixty-two probands with a life-time history of cannabis use disorder, alcohol dependence, anxiety disorders or no history of any disorder, and their first-degree relatives and spouses. MEASUREMENTS: Cannabis use disorders and other DSM-III-R disorders in the relatives and spouses using the Schedule for Affective Disorders and Schizophrenia. FINDINGS: Results reveal an elevated risk of life-time history of cannabis use disorders among siblings [odds ratio (OR: 3.6), adult offspring (OR): 6.9], and spouses (OR: 4.4) of probands with cannabis use disorders. There is a latent familial factor underlying cannabis use disorders that was shared partially with alcohol abuse/dependence. Comorbid mood and anxiety disorders aggregated independently from cannabis use disorders in families. Equal elevation in the magnitude of the association among the first-degree adult relatives and spouses of probands with a cannabis use disorder suggests the probable contribution of both environmental and genetic factors. CONCLUSIONS: These findings support a family-based approach to drug abuse intervention and the importance of future research concerning environmental mediators of familial transmission of drug abuse.
Authors: Wilson M Compton; Kevin P Conway; Frederick S Stinson; James D Colliver; Bridget F Grant Journal: J Clin Psychiatry Date: 2005-06 Impact factor: 4.384
Authors: M T Tsuang; M J Lyons; S A Eisen; J Goldberg; W True; N Lin; J M Meyer; R Toomey; S V Faraone; L Eaves Journal: Am J Med Genet Date: 1996-09-20
Authors: W R True; H Xian; J F Scherrer; P A Madden; K K Bucholz; A C Heath; S A Eisen; M J Lyons; J Goldberg; M Tsuang Journal: Arch Gen Psychiatry Date: 1999-07
Authors: John I Nurnberger; Ryan Wiegand; Kathleen Bucholz; Sean O'Connor; Eric T Meyer; Theodore Reich; John Rice; Marc Schuckit; Lucy King; Theodore Petti; Laura Bierut; Anthony L Hinrichs; Samuel Kuperman; Victor Hesselbrock; Bernice Porjesz Journal: Arch Gen Psychiatry Date: 2004-12
Authors: L J Bierut; S H Dinwiddie; H Begleiter; R R Crowe; V Hesselbrock; J I Nurnberger; B Porjesz; M A Schuckit; T Reich Journal: Arch Gen Psychiatry Date: 1998-11
Authors: K R Merikangas; M Stolar; D E Stevens; J Goulet; M A Preisig; B Fenton; H Zhang; S S O'Malley; B J Rounsaville Journal: Arch Gen Psychiatry Date: 1998-11
Authors: Derek B Kosty; Richard F Farmer; John R Seeley; Jeff M Gau; Susan C Duncan; Peter M Lewinsohn Journal: Addiction Date: 2015-04-27 Impact factor: 6.526
Authors: Karin J H Verweij; Brendan P Zietsch; Michael T Lynskey; Sarah E Medland; Michael C Neale; Nicholas G Martin; Dorret I Boomsma; Jacqueline M Vink Journal: Addiction Date: 2010-03 Impact factor: 6.526